Remove Drug Development Remove healthcare technology Remove Pharmaceuticals
article thumbnail

Merative formerly IBM Watson Health poised to launch raft of new products in 2025

Lloyd Price

With significant investments and a focus on innovation, Merative is poised to play a major role in shaping the future of healthcare data analytics and technology. Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions.

article thumbnail

HealthTech M&A 2025 Predictions: Europe and USA

Lloyd Price

The increasing adoption of digital health technologies, the growing importance of AI and ML, and the evolving regulatory landscape will continue to shape the deal landscape. Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

HLTH 2024: What are the key talking points likely to be?

Lloyd Price

Overall, HLTH 2024 is expected to be a thought-provoking and informative event that will shape the future of healthcare. Nelson Advisors work with Healthcare Technology Founders, Owners and Investors to assess whether they should 'Build, Buy, Partner or Sell' in order to maximise shareholder value.

article thumbnail

B2C2B models gaining traction in HealthTech

Lloyd Price

They can directly engage with consumers while providing data and insights to healthcare providers to support patient-centered care. Email lloyd@nelsonadvisors.co.uk Nelson Advisors Healthcare Technology Newsletter > Mergers, Acquisitions, Growth, Strategy, Insights & Predictions. Subscribe Today! Subscribe Today!

article thumbnail

HealthTech M&A valuation multiples: 10 Key Variables in 2025

Lloyd Price

Companies with a strong technology moat are typically valued at a premium to those that do not have a moat. Key Regulatory Considerations in Healthtech FDA Approval: For medical devices and pharmaceuticals, FDA approval is often a critical requirement for market entry. Delays or denials can significantly impact valuation.

article thumbnail

How can Palantir win 'hearts and minds' to deliver the NHS England Federated Data Platform?

Lloyd Price

By implementing these strategies, Palantir can effectively address public concerns, build trust, and gain acceptance for its role in delivering the NHS Federated Data Platform, ultimately contributing to improved patient care and healthcare outcomes in England. Palantir's plans for healthcare are ambitious. Buy, build or partner?

article thumbnail

A guide to connected health device and remote patient monitoring vendors

Healthcare IT News - Telehealth

The Biofourmis armband wearable, Everion, is worn 24/7 and captures the patient’s temperature, blood oxygenation and numerous other physiologic signals to detect signs of decompensation, while the patient also reports any symptoms to their healthcare provider through a mobile app. iRhythm Technologies.